Post-Market Surveillance of a Blood Glucose Test Strip Demonstrates No Evidence of Interference on Clinical Accuracy in a Large Cohort of People with Type 1 or Type 2 Diabetes

BACKGROUND: Regulations and industry guidance relating to testing for interference in blood glucose monitoring (BGM) systems continue to focus on in vitro laboratory bench tests. Post-market surveillance (PMS) in a clinical setting allows for BGM accuracy assessments to evaluate the impact of real-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Stuart, Setford, Steven, Grady, Mike, Liu, Zuifang, Cameron, Hilary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846393/
https://www.ncbi.nlm.nih.gov/pubmed/34486429
http://dx.doi.org/10.1177/19322968211042352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846393/
https://www.ncbi.nlm.nih.gov/pubmed/34486429
http://dx.doi.org/10.1177/19322968211042352

Ejemplares similares